Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-29

FDA Approved: KLOXXADO — Original Application (Hikma Specialty USA Inc.)

View source ↗

Summary

The FDA approved KLOXXADO (naloxone hydrochloride) through an original application by Hikma Specialty USA Inc. to reverse opioid overdoses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KLOXXADO (Naloxone HCl)

Snippet

ORIG AP for KLOXXADO (NALOXONE HCL)